Open access · CC-BY
via OpenAlex
CoQ10 and Mitochondrial Dysfunction in Alzheimer’s Disease
Antioxidants · 2024 · ▲ 59 citations
Abstract
The progress in understanding the pathogenesis and treatment of Alzheimer’s disease (AD) is based on the recognition of the primary causes of the disease, which can be deduced from the knowledge of risk factors and biomarkers measurable in the early stages of the disease. Insights into the risk factors and the time course of biomarker abnormalities point to a role for the connection of amyloid beta (Aβ) pathology, tau pathology, mitochondrial dysfunction(definition), and oxidative stress in the onset and development of AD. Coenzyme Q10 (CoQ10) is a lipid antioxidant and electron transporter in the mitochondrial electron transport system. The availability and activity of CoQ10 is crucial for proper mitochondrial function and cellular bioenergetics. Based on the mitochondrial hypothesis of AD and the hypothesis of oxidative stress, the regulation of the efficiency of the oxidative phosphorylation system by means of CoQ10 can be considered promising in restoring the mitochondrial function impaired in AD, or in preventing the onset of mitochondrial dysfunction and the development of amyloid and tau pathology in AD. This review summarizes the knowledge on the pathophysiology of AD, in which CoQ10 may play a significant role, with the aim of evaluating the perspective of the pharmacotherapy of AD with CoQ10 and its analogues.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/antiox13020191
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Fišar, Z., & Hroudová, J. (2024). CoQ10 and Mitochondrial Dysfunction in Alzheimer’s Disease. <em>Antioxidants</em>. https://doi.org/10.3390/antiox13020191
Vancouver
Fišar Z, Hroudová J. CoQ10 and Mitochondrial Dysfunction in Alzheimer’s Disease. Antioxidants. 2024. doi:10.3390/antiox13020191.
BibTeX
@article{zdenk2024CoQand,
title = {CoQ10 and Mitochondrial Dysfunction in Alzheimer’s Disease},
author = {Zdeněk Fišar and Jana Hroudová},
journal = {Antioxidants},
year = {2024},
doi = {10.3390/antiox13020191},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
European Neuropsychopharmacology 2019
Citation only
MITOCHONDRIAL DYSFUNCTION IN ALZHEIMER'S DISEASE
Oxidative Medicine and Cellular Longevity 2014
Open access · CC-BY
Mitochondrial Dysfunction: Different Routes to Alzheimer’s Disease Therapy
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013
Open access · OA
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2008
Open access · OA
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Cell Metabolism 2013
Open access · OA
Mitochondrial Dynamics in the Regulation of Nutrient Utilization and Energy Expenditure
Experimental Neurology 2009
Citation only